IBTA e-News March 2019 now out

By 30th March 2019 May 1st, 2019 News archive
[30 March 2019] The IBTA's monthly e-News has been released and has emailed to all subscribers. To sign up to receive your copy, click here.

You can also read the IBTA e-News March 2019 edition in full online here.

Some of the highlights from this month's round-up:

  • A Phase 2 clinical trial in children with ependymoma, published in the Journal of Clinical Oncology, has indicated that radiation immediately after surgery can nearly triple survival.
  • In a study that used high-resolution MRI images to measure the protein content of glioma tumours, researchers found that the stronger the protein signal, the poorer the prognosis. If the images indicate a potentially fast-growing tumour, then it may be possible to deliver a more intensive therapy and improve patient outcomes, the authors suggest.
  • The European Organisation for Research and Treatment of Cancer (EORTC) has published a landmark manifesto for ‘a new approach for better medicine in Europe establishing treatment optimisation as part of personalized medicine development’. It provides an international framework for research into personalised cancer therapies i.e. therapies tailored to the patient’s molecular, genetic, or other specific details of a patient’s profile.
  • In a study published in the Proceedings of the National Academy of Sciences, scientists found that a new compound, dubbed RIPGBM, kills glioblastoma stem-like cells cultured from patients' tumours with more than 40 times the potency of temozolomide.
  • A recently published review in Oncology focuses on the clinical developments and management of newly diagnosed glioblastoma and includes a discussion on the incorporation of molecular features into glioblastoma classification.
  • A clinical study conducted at the North Bristol NHS Trust (UK) has shown that the convection enhanced delivery device system, which is already used for treating Parkinson’s disease, may provide a way to carry chemotherapy and other drugs across the blood-brain barrier to treat brain tumours.

Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 6,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.

To see an archive of existing e-News issues, click here.

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.